MedPath
FDA Approval

ACD

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Terumo BCT, Ltd.
DUNS: 233649834
Effective Date
January 10, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
VS-01(0.8 g in 100 mL)
Glucose(2.45 g in 100 mL)
Gadofosveset trisodium(2.2 g in 100 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Terumo BCT, Ltd.

Terumo BCT, Ltd.

233649834

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ACD A

Product Details

NDC Product Code
14537-817
Application Number
BA010228
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2017
VS-01Active
Code: 2968PHW8QPClass: ACTIMQuantity: 0.8 g in 100 mL
GlucoseActive
Code: LX22YL083GClass: ACTIBQuantity: 2.45 g in 100 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
Code: B22547B95KClass: ACTIMQuantity: 2.2 g in 100 mL

ACD A

Product Details

NDC Product Code
14537-815
Application Number
BA010228
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2017
VS-01Active
Code: 2968PHW8QPClass: ACTIMQuantity: 0.8 g in 100 mL
GlucoseActive
Code: LX22YL083GClass: ACTIBQuantity: 2.45 g in 100 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
Code: B22547B95KClass: ACTIMQuantity: 2.2 g in 100 mL
© Copyright 2025. All Rights Reserved by MedPath